Table 3.
Age‐Adjusted Prevalence % (95% CI)* | Adjusted Odds Ratio (95% CI) | ||
---|---|---|---|
Model 1 † | Model 2 ‡ | ||
CVD | |||
No NAFLD | 4.65 (4.16‐5.14) | Reference | Reference |
NAFLD | 7.70 (6.83‐8.57) § | 1.82 (1.54‐2.15) | 1.5 (1.21‐1.84) |
ASCVD ≥7.5% | |||
No NAFLD | 19.94 (19.42‐20.46) | Reference | Reference |
NAFLD | 28.05 (26‐30.11) § | 3.08 (2.46‐3.86) | 1.96 (1.47‐2.6) |
CVD or ASCVD ≥7.5% | |||
No NAFLD | 21.04 (20.41‐21.67) | Reference | Reference |
NAFLD | 29.66 (27.55‐31.77) § | 2.73 (2.23‐3.34) | 1.81 (1.41‐2.32) |
Age adjustment is based on the direct method to the census 2000 population, using the age groups 20‐44, 45‐64, and ≥65 years.
Model 1, adjusted for age and race.
Model 2, adjusted for Model 1 plus current smoker, MS, cancer, and COPD; due to multicollinearity between MS and metabolic components, the letters were excluded.
Significantly different from no NAFLD.